Provided By Business Wire
Last update: May 23, 2025
Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.
NYSE:A (12/23/2025, 11:54:54 AM)
138.33
-0.19 (-0.14%)
Find more stocks in the Stock Screener


